Visos naujienos

With the global health crisis unfolding, it is very important to help the personnel who are sacrificing themselves for the benefit of the whole country and to ensure safe working conditions for them, according to Agnė Gaižauskienė, CEO of IFPA. 

“Lithuanian hospitals lack personal protection equipment: respirators, disposable coveralls and other items. Now more than ever, we need a concerted effort and close collaboration to achieve the common goal, so we have joined other business organisations and contributed support directed specifically at procuring personal protection equipment for healthcare professionals. We are currently working hard to secure  speedy delivery of the equipment so that the personnel dealing directly with the COVID-19 virus receive the much needed protection as soon as possible,” Ms Gaižauskienė said.

IFPA together with other local partners have raised a total of nearly EUR 360,000 for the purchase of personal protection equipment. Ms Gaižauskienė added that the Innovative Pharmaceutical Industry Association continues to look for more opportunities to help healthcare professionals and workers.

“We have also initiated an additional IFPA member support fund within the association, which will be used to help medical staff. We will continue to do our utmost to take care of those who are rescuing lives every day and are currently in the forefront of the fight against COVID-19,” Ms Gaižauskienė said.

About the Innovative Pharmaceutical Industry Association (IFPA) 

The Innovative Pharmaceutical Industry Association (IFPA) was established in October 1997. IFPA currently has 17 members* and unites innovative pharmaceutical companies and their representative offices registered in Lithuania. These are companies that develop innovative proprietary medicinal products and promote ethical practices. In 2017 through 2018, IFPA members contributed EUR 67.4m to clinical research, social projects, education and taxes in Lithuania. Since 2004, IFPA has been a member of the European Federation of Pharmaceutical Industries and Associations (EFPIA).